Implantable Cardiovascular Devices Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Implantable Cardiovascular Devices, Including Pacemakers, Implantable Cardioverter-defibrillators, Ventricular Assist Devices and Cardiac Loop Recorders, Are Designed to Help Manage a Person's Heart Rate or Rhythm Problems and to Control or Monitor Irregular Heartbeats in People with Certain Arrhythmias and Heart Failure, for Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias. It is Used in Patients with Bradycardia, Ventricular Arrhythmias or Supraventricular Arrhythmias.Implantable Cardiovascular Devices Can Help Support Cardiac Patients by Using Painless Electrical Signals to Keep the Heart Beating Regularly and Improve Function when the Device is Placed Through a Minimally Invasive Procedure. in Addition to Delivering Electrical Pulses, the Implantable Device is Now Able to Send Clinical Data Directly to the Physician Using Remote Monitoring. It Will Continuously Collect Information About the Heart Rhythm, Which is Transmitted Wirelessly to Medical Personnel when Symptoms Occur, Thus Facilitating Remote Monitoring, Which Doctors Can Use to Manage the Condition and Potentially Detect Signs of Deterioration Earlier. Not Only Do These Devices Improve Heart Disease Symptoms, but They Have Been Shown to Improve Long-term Survival Rates.These Devices Continue to Get Smaller, More Efficient, and Have Longer Battery Life. These Devices Are Usually Inserted Under Local Anesthesia and They Are Located Just Below the Collarbone to Avoid Being Visible from the Outside of the Body. Most Devices Require Periodic Monitoring, Usually Once a Year, on an Outpatient Basis.
This report aims to provide a comprehensive presentation of the global market for Implantable Cardiovascular Devices study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Implantable Cardiovascular Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Cardiovascular Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Implantable Cardiovascular Devices companies in 2021 (%)
The global Implantable Cardiovascular Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Cardioverter Defibrillators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Cardiovascular Devices include Medtronic, Abbott, Boston Scientific, AbioMed, Philips Healthcare, Biotronik Se, Angel Medical Systems, Berlin Heart and LivaNova, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Implantable Cardiovascular Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Implantable Cardiovascular Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Type, 2021 (%)
Implantable Cardioverter Defibrillators
Implantable Pacemakers
Insertable Loop Recorders
Ventricular Assist Devices
Global Implantable Cardiovascular Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, by Application, 2021 (%)
Hospital
Specialized Hospital
Others
Global Implantable Cardiovascular Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Implantable Cardiovascular Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Cardiovascular Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Cardiovascular Devices revenues share in global market, 2021 (%)
Key companies Implantable Cardiovascular Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Implantable Cardiovascular Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
AbioMed
Philips Healthcare
Biotronik Se
Angel Medical Systems
Berlin Heart
LivaNova
Shree Pacetronix
Jarvik Heart
EBR Systems
Medico SpA
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
- 1.1 Research Objective
- 1.2 Scope of the Study
- 1.3 Definition
- 1.4 Assumptions & Limitations
Chapter 2: Executive Summary
- 2.1 Market Snapshot
Chapter 3: Market Dynamics Analysis and Trends
- 3.1 Market Dynamics
- 3.1.1 Market Growth Drivers
- 3.1.2 Market Restraints
- 3.1.3 Available Market Opportunities
- 3.1.4 Influencing Trends
Chapter 4: Market Factor Analysis
- 4.1 Porter’s Five Forces Analysis
- 4.2 Bargaining power of suppliers
- 4.3 Bargaining power of buyers
- 4.4 Threat of substitute
- 4.5 Threat of new entrants
- 4.6 Porter's Five Forces Analysis
- 4.7 Value Chain Analysis
- 4.8 Market Impact Analysis
- 4.9 Regional Impact
- 4.10 Pricing Analysis
- 4.11 Import-Export Analysis
Chapter 5: Competitive Landscape
- 5.1 Company Market Share/Positioning Analysis
- 5.2 Key Strategies Adopted by Players
- 5.3 Vendor Landscape
- 5.3.1 List of Suppliers
- 5.3.2 List of Buyers
Chapter 6: Analyst Viewpoint and Conclusion
- 6.1 Recommendations and Concluding Analysis
- 6.2 Potential Market Strategies
Chapter 7: RESEARCH METHODOLOGY
- 7.1 Overview
- 7.2 Data Mining
- 7.3 Secondary Research
- 7.4 Primary Research
- 7.4.1 Primary Interviews and Information Gathering Process
- 7.4.2 Breakdown of Primary Respondents
- 7.5 Forecasting Model
- 7.6 Market Size Estimation
- 7.6.1 Bottom-Up Approach
- 7.6.2 Top-Down Approach
- 7.7 Data Triangulation
- 7.8 Validation
Research Methodology:
Implantable Cardiovascular Devices Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|